Skip to main content
Caplight Logo









Taiwan Mitochondrion Applied Technology Co., Ltd.

Taiwan Mitochondrion Applied Technology Co., Ltd.

Private
TaiwanHealthcare & Life Scienceshttps://www.taimito.com/

Last Round

Angel

Jan 13, 2015

Total Funding Raised

$160,000

Company Overview

Taiwan Mitochondrion Applied Technology Co., Ltd. is a biotechnology company that develops regenerative medicine and mitochondrial technology, including stem cell and immune cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

mitochondrial researchregenerative medicinemitochondrial reconstruction technologyMRTautologous cell therapystem cell therapymitochondrial dysfunctionanti-aging medicineaesthetic medicineODM servicesOEM servicesmitochondrial health supplementslongevity sciencecell culture mediummetabolomicsbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Taiwan Mitochondrion Applied Technology Co., Ltd. Comparables

Compare Taiwan Mitochondrion Applied Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Taiwan Mitochondrion Applied Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PAEAN Biotechnology
81%
Mitrix Bio
79%
Minovia Therapeutics
78%

Taiwan Mitochondrion Applied Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelJan 13, 2015

Taiwan Mitochondrion Applied Technology Co., Ltd. Investors

Notable investors and investment history

Taiwan Mitochondrion Applied Technology Co., Ltd. investors
InvestorRounds
National Development FundAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 13, 2015

    $160K round led by National Development Fund

Taiwan Mitochondrion Applied Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Taiwan Mitochondrion Applied Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Taiwan Mitochondrion Applied Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTaiwan
Year Founded2014
Last FundingJan 13, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?